Seroquel
In brief
- Available from pharmacies and distributors (AstraZeneca and many generics) — quetiapine (Seroquel/Seroquel XR) is legally prescription-only in most countries, though some pharmacies may sell it without a prescription or receipt; use without medical supervision is not recommended.
- Seroquel (quetiapine) is used for schizophrenia, bipolar disorder (mania and depression) and as an adjunct in major depressive disorder; it is an atypical antipsychotic that primarily antagonizes dopamine D2 and serotonin 5-HT2A receptors and also has effects at histamine H1 and alpha-1 adrenergic receptors, producing antipsychotic and sedative effects.
- Usual dosages vary by indication: schizophrenia — start 25 mg twice daily, target 300–400 mg/day (up to 800 mg/day max); acute bipolar mania — start 50 mg twice daily, escalate to ~400 mg/day by Day 4 (up to 800 mg/day); bipolar depression — start 50 mg nightly, titrate to 300 mg at bedtime (max 300 mg); adjunct in depression — Seroquel XR 50 mg at bedtime, up to 150–300 mg XR.
- Administered orally as immediate‑release tablets (25–400 mg) or extended‑release (XR) tablets (50–400 mg); do not crush or chew XR tablets and keep in original packaging as directed.
- Onset: sedative effects often occur within 1–2 hours; mood and psychotic symptom improvements may begin within days but typically take 1–4 weeks or longer for meaningful benefit.
- Duration: plasma half-life is approximately 6 hours for immediate‑release (XR formulations extend exposure), so daily dosing is used for ongoing control; sedative effects commonly last several hours after a dose.
- Alcohol warning: avoid alcohol while taking Seroquel — alcohol increases sedation, dizziness, risk of respiratory depression and orthostatic hypotension.
- The most common side effect is drowsiness/sedation (other frequent effects include dizziness, dry mouth, weight gain, constipation and orthostatic hypotension).
- Would you like to try seroquel without a prescription?
Basic Seroquel Information
- INN (International Nonproprietary Name): Quetiapine
- Brand Names Available In Canada (English): Seroquel; Seroquel XR; multiple generics labelled as quetiapine from manufacturers such as Teva and Sandoz
- ATC Code: N05AH04 (Atypical, Second-Generation Antipsychotic)
- Forms & Dosages: Immediate-release tablets 25 mg, 50 mg, 100 mg, 150 mg, 200 mg, 300 mg, 400 mg; Extended-release (XR) tablets 50 mg, 150 mg, 200 mg, 300 mg, 400 mg
- Manufacturers In Canada (English): AstraZeneca (originator Seroquel/Seroquel XR) and multiple generic suppliers including Teva and Sandoz
- Registration Status In Canada (English): Marketed in Canada as Seroquel and Seroquel XR; prescription-only with product monographs and DINs when marketed
- OTC / Rx Classification: Prescription (Rx) only
Critical Warnings & Restrictions In Canada
Safety-First Summary For Patients And Caregivers
If a person is switching or starting quetiapine, do not stop it abruptly without prescriber guidance.
Report severe drowsiness, fainting, a very fast or irregular heartbeat, trouble breathing, or any new thoughts of self-harm to the prescriber immediately or call 911.
Prioritise medication reconciliation at every transfer of care, for example on admission or discharge from hospital and at community follow-up appointments.
- Emergency Signs: extreme sedation, loss of consciousness, severe hypotension, chest pain, severe shortness of breath, suicidal thoughts.
- Contact Points: local emergency department, provincial poison centre, prescriber, community pharmacist.
- Medication Card To Carry: drug name (quetiapine / Seroquel / Seroquel XR), dose, prescriber name, DIN.
Quetiapine (INN) is marketed in Canada as Seroquel and Seroquel XR and is prescription-only.
It is contraindicated for dementia-related psychosis because use in this population is associated with increased mortality risk.
Health Canada and provincial formularies call for informed-consent style counselling when starting high-risk antipsychotics and for baseline metabolic monitoring.
Recommended baseline checks include weight, fasting glucose or HbA1c, lipid profile, blood pressure, and an ECG if there is cardiac risk.
Repeat testing should follow local protocol and the prescriber’s plan.
- Baseline Labs Checklist: weight/BMI, fasting glucose or HbA1c, lipids, BP, ECG if indicated.
- Monitoring Schedule: early follow-up within weeks for sedation and orthostatic symptoms, metabolic labs at baseline and periodically thereafter as per provincial guidance.
- Who To Call For Side Effects: prescriber, community pharmacist, poison centre, local emergency services.
High-Risk Groups (Elderly, Pregnant, Indigenous Health Considerations)
Elderly patients with dementia-related psychosis have an increased mortality risk and quetiapine should be avoided in that indication.
When treating older adults start low (for example, 25 mg/day) and titrate slowly because they are more sensitive to sedation, orthostatic hypotension and anticholinergic effects.
Pregnancy and breastfeeding require a careful risk–benefit discussion with obstetrics and perinatal mental-health services.
Neonates exposed in utero may have withdrawal or respiratory issues and need neonatal monitoring after delivery.
For Indigenous patients, culturally safe care is essential and involvement of community health workers can improve follow-up and monitoring access.
- Tailored Monitoring Steps: arrange community bloodwork access, schedule home or clinic BP and weight checks, coordinate with local Indigenous health programs for follow-up.
- Referral Points: obstetrics/perinatal mental-health, geriatrics, Indigenous health services, community pharmacy for medication reconciliation.
Interaction With Activities (Driving, Machinery, Workplace Safety Under Canadian Law)
Sedation, dizziness and orthostatic hypotension occur commonly with quetiapine and can impair driving and operation of heavy machinery.
Patients should not drive or operate heavy machinery until they know how quetiapine affects them.
Workers in safety-sensitive roles should consult the treating physician and occupational health, and disclose limitations where required by provincial rules.
- Assess sedation risk before returning to driving.
- Document workplace restrictions and communicate them through occupational health if needed.
- Arrange temporary duty changes for safety-sensitive tasks until effects are known.
Q&A — “Can I Drive After Taking It In Canada?”
Short answer: do not drive until you are sure quetiapine does not impair you.
If you feel drowsy or dizzy do not drive and notify your prescriber or pharmacist about these effects.
Provincial road-safety rules and employer policies may require reporting if you work in a safety-sensitive job.
Usage Basics For Canadians
INN, Brand Names Available In Canada
Quetiapine is the International Nonproprietary Name (INN) for the drug commonly known here as seroquel.
In Canada it appears as Seroquel and Seroquel XR from AstraZeneca and as multiple generics from manufacturers such as Teva and Sandoz.
| Brand / Generic | Common Pack Sizes | Release Form |
|---|---|---|
| Seroquel (AstraZeneca) | 10, 30, 60, 100 tablets | Immediate-Release |
| Seroquel XR (AstraZeneca) | 30, 60, 100 tablets | Extended-Release |
| Quetiapine (Teva, Sandoz and other generics) | 10, 30, 60, 100 tablets | Immediate-Release / XR |
Legal Classification Under Health Canada (Prescription Vs OTC)
Quetiapine is prescription-only in Canada and carries a Drug Identification Number (DIN) when marketed.
Dispensing requires a valid prescription and pharmacists must provide counselling and record interventions according to provincial regulations.
- Retail Vs Hospital Supply Differences: hospitals may use formulary procurement; community pharmacies dispense against a prescription.
- Community Pharmacy Obligations: counselling on indications, adverse effects, monitoring and interactions; documentation of interventions.
- Meaning Of DIN: unique identifier for a marketed product in Canada linked to the product monograph and labelling.
Canadian Dosing Guide
Standard Regimens (Health Canada Approved)
Schizophrenia in adults commonly starts around 25 mg twice daily with titration toward 300–400 mg/day divided across 2–3 doses; the maximum is 800 mg/day.
Bipolar mania often begins at 50 mg twice daily with a target of 400 mg by day 4 and a maximum of 800 mg/day.
Bipolar depression dosing typically starts at 50 mg once daily and is titrated to 300 mg at bedtime with a maximum of 300 mg for that indication.
Adjunctive treatment in major depressive disorder generally uses Seroquel XR 50 mg at bedtime with titration up to 150–300 mg XR at bedtime (max 300 mg).
| Indication | Starting Dose | Target Dose | Max Dose |
|---|---|---|---|
| Schizophrenia (Adults) | 25 mg twice daily | 300–400 mg/day in 2–3 doses | 800 mg/day |
| Bipolar Mania (Acute) | 50 mg twice daily | Increase to 400 mg by Day 4 | 800 mg/day |
| Bipolar Depression (Adults) | 50 mg once daily | Titrate to 300 mg at bedtime | 300 mg/day |
| Adjunct In MDD (XR) | 50 mg XR at bedtime | Up to 150–300 mg XR at bedtime | 300 mg/day |
Adjustments For Comorbidities (E.g., Diabetes, Liver Disease)
Children and adolescents have approvals for schizophrenia from age 13 and bipolar mania from age 10, with lower starting doses and cautious titration.
Elderly patients and those with hepatic impairment should start at lower doses such as 25 mg/day and titrate slowly because quetiapine is primarily hepatically metabolized.
Renal impairment usually does not require a formal dose adjustment, but clinical monitoring is advised.
Q&A — “What If I Miss A Dose Under My Provincial Drug Plan?”
If a dose is missed, take it as soon as you remember unless it is close to the next scheduled dose; do not double up doses to make up for a missed tablet.
For coverage questions or early refills under a provincial plan, contact your provincial drug plan or community pharmacist because some plans allow emergency fills or special-authority renewals with documentation.
Interaction Chart (Canadian Context)
Food And Drinks (Coffee, Alcohol In Canadian Lifestyle)
Alcohol and quetiapine produce additive sedation and can worsen orthostatic hypotension, so avoid alcohol or minimise use, especially during dose changes.
Caffeine may blunt sedation but can increase anxiety or insomnia; there is no significant pharmacokinetic interaction with quetiapine but counsel patients on symptom effects.
- Advice: avoid heavy drinking while on quetiapine and monitor for increased sleepiness when alcohol is consumed.
- Advice: moderate caffeine intake and observe whether anxiety or insomnia worsen after starting quetiapine.
Common Drug Conflicts (Refer To Health Canada Advisories)
| Interacting Drug | Effect | Practical Action |
|---|---|---|
| Strong CYP3A4 Inhibitors (eg, certain azole antifungals) | Increase quetiapine levels | Consider dose reduction and close monitoring for sedation and hypotension |
| CYP3A4 Inducers (eg, rifampin, some anticonvulsants) | Reduce quetiapine levels | Monitor clinical effect; dose adjustment may be required |
| Other Sedatives (eg, benzodiazepines, opioids) | Additive sedation and respiratory depression risk | Avoid combined use where possible; monitor closely |
| QT-Prolonging Drugs | Potential increased QT risk | Assess baseline ECG and monitor if combining |
| Antihypertensives | May increase orthostatic hypotension | Monitor BP and titrate doses carefully |
Always consult provincial drug interaction resources and your pharmacist for a full reconciliation of interactions and monitoring plans.
User Reports & Trends In Canada
Canadian Patient Forums And Review Platforms
Common themes from patient reports include early sedation, weight gain, improved sleep for some, and mixed effects on cognition.
Many users compare immediate-release and XR products and note XR is more convenient for once-daily dosing with less morning sedation for some people.
- Tips Shared By Patients: take at bedtime to reduce daytime drowsiness, ask prescriber for slow titration if sedation is a problem.
- Cautions Shared: beware of sourcing medication online from non-Canadian sellers because counterfeit risk is higher.
Community Pharmacy Feedback
Pharmacists often see adherence challenges due to daytime tiredness and frequent requests to switch to XR formulations for once-daily dosing.
Pharmacists play a central role in metabolic monitoring reminders and in obtaining refill authorizations under provincial plans.
Definition Of Common Concern And Usual Pharmacy Action:
- Patient Concern → Pharmacist Action: morning sedation → advise bedtime dosing and discuss XR options.
- Patient Concern → Pharmacist Action: weight gain or metabolic changes → flag for baseline labs and liaise with prescriber.
- Patient Concern → Pharmacist Action: difficulty obtaining refills → assist with special-authority paperwork and communicate with prescriber.
Access & Purchase Options
National Pharmacy Chains (Shoppers Drug Mart, Rexall, London Drugs, Jean Coutu)
In-store prescription fills include pharmacist counselling and adjudication with private or public drug plans at point of sale.
Chains commonly offer services such as medication reviews, blister packing and automated reminders to support adherence.
- Services: medication reviews, blister or bubble packaging, adherence reminder programs, private counselling rooms.
- Packaging: products carry DINs and are often in blister packs of 10, 30, 60 or 100 tablets; some packs are child-resistant or tamper-evident.
Online Pharmacies In Canada & Provincial Restrictions
Canadian online pharmacies and telepharmacy services require a valid prescription and must be licensed in the province they operate from.
Inter-provincial shipping rules and pharmacy college regulations vary; check the provincial college of pharmacists rules before ordering.
In our online pharmacy, seroquel is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.
- Checklist To Verify An Online Pharmacy: visible pharmacy licence number, provincial college registration links, contact phone number and physical address.
- Warning: avoid international sellers that do not show Canadian licensure to reduce risk of counterfeit or substandard products.
Mechanism & Pharmacology
Simplified Explanation (Patient-Friendly)
Quetiapine is an atypical antipsychotic that affects several neurotransmitter receptors to reduce psychotic symptoms and stabilise mood.
Its antipsychotic action relates mainly to dopamine D2 and serotonin 5-HT2 receptor modulation, while sedation largely comes from histamine H1 antagonism.
- Main Receptor Actions: 5-HT2 antagonism, D2 antagonism, H1 antagonism.
- Clinical Effects: antipsychotic, mood stabiliser, sedative.
Clinical Terms (Health Canada Approved Monograph References)
Quetiapine has immediate-release and extended-release (XR) forms; XR allows once-daily dosing and provides steadier exposure over 24 hours.
Do not crush or chew XR tablets because this alters release characteristics.
Metabolism is primarily hepatic via CYP3A4 which explains many drug interactions and the need for dose adjustments with strong inhibitors or in liver impairment.
- Immediate-Release: multiple dosing per day as prescribed.
- Extended-Release (XR): once-daily dosing at bedtime for many indications; do not crush/chew.
- Metabolism Notes: mainly via CYP3A4, monitor when combined with inhibitors or inducers of this enzyme.
Indications & Off-Label Uses In Canada
Approved Indications (DIN)
| Indication | Typical Target Dose | Age Approvals |
|---|---|---|
| Schizophrenia | 300–400 mg/day (divided) | Adults; adolescents ≥13 for some formulations |
| Bipolar Mania | 400 mg/day target | Adults; children ≥10 for some paediatric approvals |
| Bipolar Depression | 300 mg at bedtime | Adults |
| Adjunct In Major Depressive Disorder (XR) | 50–300 mg XR at bedtime | Adults |
Common Off-Label Practices (Canadian Physicians)
Off-label uses occasionally include short-term management of severe insomnia or behavioural symptoms in select cases, but these require caution because of fall risk and metabolic effects.
- Safe Off-Label Practice Steps: document informed consent, set a clear review timeline, use the lowest effective dose and arrange monitoring for adverse effects.
- Recommendation: consult specialists or local guidelines before prolonged off-label prescribing.
Key Clinical Findings
Canadian And International Studies 2022–2025
Recent evidence highlights quetiapine’s effectiveness in acute mania and schizophrenia and its metabolic safety signals including weight gain, dyslipidemia and glucose changes.
Extended-release formulations have shown improved adherence in some cohorts due to once-daily dosing convenience.
- Key Efficacy Findings: effective in schizophrenia and bipolar disorder; beneficial as adjunct in major depressive disorder at XR doses.
- Common Safety Signals: early sedation, weight gain, lipid and glucose elevations requiring monitoring.
- Adherence Data: XR formulations often preferred for once-daily dosing and fewer missed doses.
Ongoing Health Canada Safety Monitoring
Health Canada continues post-market surveillance of quetiapine and encourages reporting of adverse drug reactions.
Healthcare professionals and patients can report suspected reactions through MedEffect Canada.
- How To Report AEs: include product name/DIN, dose, dates, description of symptoms and outcome when reporting.
- What To Document: lot number if available, where product was obtained, and contact details for follow-up.
Alternatives Matrix
Comparable Medicines With DIN In Canada
| Drug | Typical Uses | Main Pros | Main Cons |
|---|---|---|---|
| Olanzapine (Zyprexa) | Schizophrenia, Bipolar | Strong antipsychotic efficacy | High metabolic risk (weight, lipids) |
| Risperidone | Schizophrenia, Bipolar | Effective across indications | Prolactin elevation, EPS at higher doses |
| Aripiprazole (Abilify) | Schizophrenia, Bipolar, Adjunct in Depression | Lower metabolic burden, activating | Akathisia risk |
| Clozapine (Clozaril) | Treatment-Resistant Schizophrenia | Superior efficacy for resistant cases | Requires blood monitoring, significant side-effect profile |
| Lurasidone (Latuda) | Schizophrenia, Bipolar Depression | Lower metabolic effects | Must be taken with food for absorption |
Pros And Cons Checklist
- Define efficacy goals with prescriber before switching products.
- Prioritise side-effect concerns such as weight gain versus activation or akathisia.
- Consider monitoring burden, drug–drug interactions and hepatic metabolism when choosing alternatives.
- Check provincial coverage and cost differences between branded Seroquel and generics.
- Use shared decision-making and involve the pharmacist for counselling on switching and monitoring.
Common Questions From Canadian Patients
- How Quickly Does It Work? — Sedation may be noticeable within hours; antipsychotic and mood-stabilising effects usually take days to weeks with proper titration.
- Will It Make Me Gain Weight? — Weight gain is common and baseline plus periodic metabolic monitoring is recommended.
- Is It Addictive? — Quetiapine is not considered classically addictive, but abrupt stopping can cause withdrawal symptoms including insomnia; taper under medical supervision.
- Can I Drink Alcohol? — Avoid or minimise alcohol due to additive sedation and safety risks, particularly during dose changes.
- What About Travel And Storage? — Store at 15–30°C and carry medication in original packaging with a copy of the prescription for air travel.
For plan-specific coverage questions contact your provincial drug plan or community pharmacist for details.
Coverage & Purchase Comparison Table
Province/Plan Coverage Summary
| Province / Plan | Coverage | Typical Patient Cost | Special-Authority Notes |
|---|---|---|---|
| Ontario Drug Benefit (ODB) | Partial / Limited | Dispense fee + copay for eligible seniors/beneficiaries | Listing tied to approved indications and DIN; prior-authority may apply |
| BC PharmaCare | Partial / Limited | Varies by plan; generic options lower cost | May require special-authority for certain indications |
| Quebec (RAMQ) | Partial / Limited | Dispense fee + patient portion depending on eligibility | Coverage by DIN and indication; prior authorization possible |
| Alberta Health | Partial / Limited | Patient cost depends on benefit status | Generics typically preferred; special-authority routes exist |
| Other Provincial Plans | Partial / Limited | Varies by eligibility and generic vs brand | Check provincial formulary for DIN-based listing |
Step-By-Step Purchase Checklist For Canadian Patients
- Obtain a valid prescription and confirm the DIN on the label.
- Verify provincial coverage or private insurer requirements before filling.
- Ask the pharmacist about generic alternatives such as Teva or Sandoz to reduce costs.
- Keep scheduled monitoring appointments and lab orders to meet coverage or clinical requirements.
Registration & Regulation
Health Canada Approval
Seroquel, Seroquel XR and generic quetiapine products are approved and marketed with DINs in Canada for indicated uses such as schizophrenia and bipolar disorder.
Product monographs and the Drug Product Database provide the official labelling and safety information for each marketed product.
- Where To Find Product Monographs: Health Canada Drug Product Database and manufacturer websites.
- How To Report Adverse Events: MedEffect Canada reporting portal for suspected reactions.
- Check Provincial Formularies: provincial drug formularies list DINs and coverage rules for each jurisdiction.
DIN Number And Labelling Requirements
The DIN is the unique identifier for a marketed drug product in Canada and appears on the manufacturer packaging.
Bilingual labelling (English/French) and patient leaflets are often required depending on distribution and provincial rules.
- DIN → Purpose: links product to its Health Canada record and allows pharmacists to verify approved uses.
- Product Monograph → Contents: approved indications, dosing, contraindications and adverse effects.
- Bilingual Labelling → Legal Highlight: ensures safety and information accessibility across provinces.
Storage & Handling
Standard Canadian Household Conditions
Store quetiapine at room temperature between 15–30°C and protect from moisture and light.
Keep the medicine in its original packaging and do not crush or chew XR tablets.
Store out of reach of children and consider a lockbox in households with young children or people with impaired cognition.
- Temperature Control: avoid storage above 30°C and protect from humidity.
- Packaging: keep blister packs intact until use to preserve stability.
- Disposal: return unused medicine to a pharmacy take-back program; do not flush down the toilet.
Cold-Chain Requirements (Where Applicable)
Oral quetiapine formulations do not require refrigeration or cold-chain storage.
During hot weather or travel, avoid prolonged exposure to temperatures above 30°C and carry medication in a carry-on bag when flying to prevent temperature extremes in checked luggage.
- Travel Tips: bring a copy of the prescription and keep tablets in original packaging in a carry-on.
- Community Disposal Options: pharmacy take-back programs or municipal hazardous-waste events.
Guidelines For Proper Use
Canadian Pharmacist Guidance
Pharmacists should confirm the indication and exact formulation (IR vs XR) and reconcile all medicines for CYP3A4 interactions.
Counselling should include dosing time, missed-dose instructions, common adverse effects and the metabolic monitoring plan.
- Counselling Points: take XR at bedtime, missed dose rules, do not double-dose, adverse effects to report (severe sedation, hypotension, suicidal thoughts).
- Adherence Aids: blister packs, reminders and medication reviews to support long-term therapy.
- Document Interventions: record counselling and any communication with prescribers, especially for dose changes and prior-authority forms.
Provincial Health Authority Recommendations
Follow provincial clinical pathways for antipsychotic initiation and monitoring, which typically call for baseline metabolic testing and periodic reassessment.
In long-term care and Indigenous health settings, apply stewardship principles to reduce inappropriate antipsychotic use and ensure regular review.
Practical Next Steps: schedule follow-up, arrange baseline labs, and carry a medication card that lists quetiapine (INN) with formulation and prescriber details.
Delivery Across Canada (English)
| City | Region | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5–7 days |
| Montreal | Quebec | 5–7 days |
| Vancouver | British Columbia | 5–7 days |
| Calgary | Alberta | 5–7 days |
| Edmonton | Alberta | 5–7 days |
| Ottawa | Ontario | 5–7 days |
| Winnipeg | Manitoba | 5–7 days |
| Halifax | Nova Scotia | 5–7 days |
| Victoria | British Columbia | 5–7 days |
| Saskatoon | Saskatchewan | 5–9 days |
| Hamilton | Ontario | 5–9 days |
| Kitchener | Ontario | 5–9 days |
| St. John’s | Newfoundland and Labrador | 5–9 days |
Closing Practical Notes
When considering seroquel or generic quetiapine, keep a medication card with the drug name, dose, prescriber and DIN for all healthcare encounters.
Always schedule the baseline labs recommended earlier and set an early follow-up appointment to check for sedation and orthostatic symptoms.
If a severe adverse event occurs, seek emergency care and report the reaction through MedEffect Canada or your provincial reporting route.
Pharmacists are available to help with coverage questions, special-authority forms and switching between branded and generic products.
When buying online, verify the pharmacy licence and provincial registration before ordering and use community pharmacy services for counselling and monitoring.
